Biohaven Pharmaceuticals, Inc.
Clinical trials sponsored by Biohaven Pharmaceuticals, Inc., explained in plain language.
-
New drug shows promise for SMA patients in major trial
Disease control OngoingThis study tests whether adding taldefgrobep alfa to standard SMA treatments can improve muscle function in people with spinal muscular atrophy. About 269 participants, both walkers and non-walkers, will receive either the drug or a placebo for 48 weeks. The goal is to see if the…
Phase: PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 11:14 UTC
-
Hope for rare brain disorder: new drug trial targets movement decline
Disease control OngoingThis study tests whether a daily pill called troriluzole can slow the worsening of movement problems in adults with spinocerebellar ataxia (SCA), a rare brain disease. About 299 people with certain types of SCA took either the drug or a placebo for 48 weeks. The main goal was to …
Phase: PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 04, 2026 16:23 UTC